Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Stanbery

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Genes, Chromosomes & Cancer|September 13, 2011
SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesisEsther A Peterson, Laura Stanbery, Christina Li, et al.
Current Problems in Cancer|December 12, 2022
Folate Receptor as a Biomarker and Therapeutic Target in Solid TumorsOlivia Young, Nealie Ngo, Leslie Lin, et al.
Clinical Medicine Insights. Oncology|August 12, 2022
Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian CancerMinal Barve, Phylicia Aaron, Luisa Manning, et al.
Oncology Reviews|July 16, 2021
<i>Adenomatous polyposis</i> coli in cancer and therapeutic implicationsOlivia Noe, Louis Filipiak, Rachel Royfman, et al.
Future Oncology (London, England)|June 1, 2021
BRCA1/2 signaling and homologous recombination deficiency in breast and ovarian cancerRachel Royfman, Emma Whiteley, Olivia Noe, et al.
Immunotherapy|August 19, 2020
Relationship of hypothyroidism and immune response to pegylated IL-10/nivolumabMary Albrethsen, Justin Creeden, Susan Morand, et al.
Future Oncology (London, England)|February 27, 2020
Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatmentSusan Morand, Hannah Staats, Justin Fortune Creeden, et al.
Cancer Gene Therapy|January 29, 2020
PIK3CA gene aberrancy and role in targeted therapy of solid malignanciesOwen Willis, Khalil Choucair, Abdurahman Alloghbi, et al.
Oncology Reviews|December 19, 2022
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian CancerMonika Devanaboyina, Jasskiran Kaur, Emma Whiteley, et al.
International Journal of Molecular Sciences|March 28, 2024
Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian CancerMorgan Bailey, Susan Morand, Rachel Royfman, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Genes, Chromosomes & Cancer|September 13, 2011
SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesisEsther A Peterson, Laura Stanbery, Christina Li, et al.
Current Problems in Cancer|December 12, 2022
Folate Receptor as a Biomarker and Therapeutic Target in Solid TumorsOlivia Young, Nealie Ngo, Leslie Lin, et al.
Clinical Medicine Insights. Oncology|August 12, 2022
Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian CancerMinal Barve, Phylicia Aaron, Luisa Manning, et al.
Oncology Reviews|July 16, 2021
<i>Adenomatous polyposis</i> coli in cancer and therapeutic implicationsOlivia Noe, Louis Filipiak, Rachel Royfman, et al.
Future Oncology (London, England)|June 1, 2021
BRCA1/2 signaling and homologous recombination deficiency in breast and ovarian cancerRachel Royfman, Emma Whiteley, Olivia Noe, et al.
Immunotherapy|August 19, 2020
Relationship of hypothyroidism and immune response to pegylated IL-10/nivolumabMary Albrethsen, Justin Creeden, Susan Morand, et al.
Future Oncology (London, England)|February 27, 2020
Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatmentSusan Morand, Hannah Staats, Justin Fortune Creeden, et al.
Cancer Gene Therapy|January 29, 2020
PIK3CA gene aberrancy and role in targeted therapy of solid malignanciesOwen Willis, Khalil Choucair, Abdurahman Alloghbi, et al.
Oncology Reviews|December 19, 2022
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian CancerMonika Devanaboyina, Jasskiran Kaur, Emma Whiteley, et al.
International Journal of Molecular Sciences|March 28, 2024
Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian CancerMorgan Bailey, Susan Morand, Rachel Royfman, et al.
Pageof 5